- Home
- ARWR vs DOCN Comparison
ARWR vs DOCN Comparison
Compare ARWR & DOCN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ARWR | DOCN |
|---|---|---|
| Founded | 2003 | 2011 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Retail: Computer Software & Peripheral Equipment |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 10.2B | 12.2B |
| IPO Year | 2009 | 2021 |
Fundamental Metrics
Financial Performance| Metric | ARWR | DOCN |
|---|---|---|
| Price | $74.25 | $134.19 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 10 | 14 |
| Target Price | $83.40 | ★ $85.46 |
| AVG Volume (30 Days) | 2.0M | ★ 2.9M |
| Earning Date | 05-07-2026 | 05-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 99.80 | ★ 183.15 |
| EPS | N/A | ★ 0.15 |
| Revenue | $16,142,321.00 | ★ $901,427,000.00 |
| Revenue This Year | N/A | $23.80 |
| Revenue Next Year | N/A | $30.11 |
| P/E Ratio | ★ N/A | $793.93 |
| Revenue Growth | N/A | ★ 15.48 |
| 52 Week Low | $15.01 | $25.56 |
| 52 Week High | $87.83 | $187.50 |
Technical Indicators
Market Signals| Indicator | ARWR | DOCN |
|---|---|---|
| Relative Strength Index (RSI) | 44.75 | 47.20 |
| Support Level | $70.05 | $126.05 |
| Resistance Level | $77.39 | $185.98 |
| Average True Range (ATR) | 3.85 | 11.23 |
| MACD | -1.15 | -0.97 |
| Stochastic Oscillator | 24.35 | 55.57 |
Price Performance
Historical ComparisonAbout ARWR Arrowhead Pharmaceuticals Inc.
Arrowhead Pharmaceuticals Inc is a commercial-stage pharmaceutical company. It is focused on the development of medicines for diseases associated with genetic abnormalities or protein overproduction. The company develops potential RNAi therapies designed to inhibit the expression of genes known to trigger diseases. Its portfolio includes potential drugs targeting Cardiometabolic, Neuromuscular, Pulmonary, Liver, and other diseases. The company also develops RNAi products and clinical candidates designed to target different cell types within the body.
About DOCN DigitalOcean Holdings Inc.
DigitalOcean Holdings Inc is a cloud computing platform offering on-demand infrastructure and platform tools for developers, start-ups, and small and medium-sized businesses. The customers use the platform for a wide range of cases, such as web and mobile applications, website hosting, e-commerce, media and gaming, personal web projects, and managed services, among many others. Geographically, the company generates maximum revenue from North America and also has a presence in Europe, Asia, and the Rest of the world.